Jerrold H Levy Selected Research

clevidipine

8/2014	A cost analysis of the impact of a new intravenous antihypertensive in managing perioperative blood pressure during cardiac surgery.
10/2008	The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.
10/2007	Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1.
5/2002	Clevidipine in adult cardiac surgical patients: a dose-finding study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerrold H Levy Research Topics

Disease

93	Hemorrhage 01/2022 - 06/2003
31	Thrombosis (Thrombus) 01/2022 - 02/2007
26	Thrombocytopenia (Thrombopenia) 01/2022 - 07/2005
25	Sepsis (Septicemia) 06/2022 - 10/2013
21	Disseminated Intravascular Coagulation 01/2022 - 10/2013
19	Inflammation (Inflammations) 06/2022 - 02/2003
17	Wounds and Injuries (Trauma) 01/2021 - 03/2008
16	COVID-19 01/2022 - 01/2020
13	Critical Illness (Critically Ill) 01/2022 - 02/2013
12	Myocardial Infarction 01/2017 - 05/2004
8	Stroke (Strokes) 01/2022 - 09/2005
8	Infections 01/2021 - 10/2018
8	Atrial Fibrillation 01/2020 - 09/2005
5	Shock 06/2022 - 02/2008
5	Venous Thromboembolism 01/2021 - 07/2012
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 09/2014
4	Septic Shock (Toxic Shock Syndrome) 01/2022 - 10/2017
4	Thromboembolism 01/2022 - 01/2020
4	Thrombophilia 12/2020 - 01/2011
4	Anaphylaxis (Anaphylactic Shock) 10/2017 - 06/2004
4	Hypertension (High Blood Pressure) 08/2014 - 05/2002
4	Vascular System Injuries 02/2011 - 06/2006
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 10/2017
3	Pulmonary Embolism 01/2022 - 10/2017
3	Renal Insufficiency (Renal Failure) 01/2020 - 09/2005
3	Left Ventricular Dysfunction 01/2020 - 12/2016
3	Hemophilia A (Haemophilia) 03/2016 - 06/2006
3	Ischemia 02/2016 - 08/2006
3	Hereditary Angioedemas 12/2014 - 01/2004
2	Hypothermia 01/2022 - 01/2020
2	Pain (Aches) 01/2022 - 06/2010
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Acidosis 01/2022 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 02/2016
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2021 - 01/2020
2	Hemostatic Disorders 01/2021 - 06/2010
2	Vasculitis (Vasculitides) 12/2020 - 01/2020
2	Necrosis 11/2019 - 02/2011
2	Anemia 03/2019 - 07/2002

Drug/Important Bio-Agent (IBA)

37	AnticoagulantsIBA 01/2022 - 06/2006
30	Hemostatics (Antihemorrhagics)IBA 01/2022 - 09/2005
22	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 07/2005
19	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 10/2018
18	Fibrinogen (Factor I)FDA Link 06/2022 - 01/2004
14	AntithrombinsIBA 12/2021 - 01/2006
12	prothrombin complex concentrates (PPSB)IBA 02/2020 - 11/2008
11	recombinant FVIIa (rFVIIa)FDA Link 03/2016 - 06/2003
10	Thrombin FDA Link 01/2021 - 02/2003
10	Dabigatran FDA Link 11/2017 - 06/2013
8	fibrin fragment D (D-dimer)IBA 06/2022 - 09/2014
7	Factor VIIa (Activated Factor VII)IBA 03/2016 - 01/2006
7	Aprotinin (Trasylol)FDA Link 02/2008 - 01/2004
6	ThrombomodulinIBA 02/2022 - 09/2017
6	Tranexamic Acid (AMCA)FDA Link 01/2022 - 09/2014
6	idarucizumabIBA 05/2017 - 07/2015
5	Thromboplastin (Tissue Factor)IBA 06/2022 - 02/2003
5	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
5	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021 - 02/2006
5	Vitamin K FDA Link 05/2020 - 05/2016
4	Platelet Factor 4IBA 06/2022 - 02/2007
4	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
4	VaccinesIBA 01/2022 - 07/2021
4	Oxygen (Dioxygen)IBA 01/2022 - 06/2003
4	FibrinIBA 12/2021 - 01/2020
4	Hemoglobins (Hemoglobin)IBA 03/2019 - 05/2011
4	Warfarin (Coumadin)FDA LinkGeneric 05/2016 - 06/2013
4	clevidipine FDA Link 08/2014 - 05/2002
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013 - 09/2004
4	AntibodiesIBA 12/2012 - 02/2007
4	Complement C5 (Complement 5)IBA 07/2011 - 08/2006
4	pexelizumabIBA 07/2011 - 08/2006
3	von Willebrand FactorIBA 06/2022 - 12/2012
3	EnzymesIBA 01/2022 - 10/2009
3	EndotoxinsIBA 12/2020 - 02/2007
3	Simendan (Levosimendan)IBA 01/2020 - 12/2016
3	CytokinesIBA 01/2020 - 02/2003
3	N(4)-oleylcytosine arabinosideIBA 01/2018 - 09/2014
3	Prasugrel Hydrochloride FDA Link 07/2013 - 07/2012
3	Clopidogrel (Plavix)FDA Link 07/2012 - 08/2004
3	HBOC 201 (Hemopure)IBA 06/2003 - 04/2002
2	ImmunosorbentsIBA 01/2022 - 11/2012
2	Peptides (Polypeptides)IBA 01/2021 - 02/2008
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2020
2	Fibrin Fibrinogen Degradation ProductsIBA 01/2020 - 09/2017

Therapy/Procedure

43	Therapeutics 12/2021 - 02/2005
20	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022 - 05/2004
13	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2020 - 05/2004
8	Critical Care (Surgical Intensive Care) 01/2021 - 02/2010
5	Extracorporeal Membrane Oxygenation 01/2022 - 05/2013
5	Length of Stay 01/2022 - 08/2004
4	Platelet Transfusion (Blood Platelet Transfusions) 12/2020 - 07/2012
4	Anticoagulation Reversal 05/2017 - 11/2008
4	Off-Label Use 05/2016 - 01/2006
3	Resuscitation 02/2020 - 04/2015
3	Hemodilution 01/2020 - 05/2009
3	Blood Transfusion (Blood Transfusions) 10/2017 - 10/2007